William D. Figg
Impact in
- Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Angiogenesis and VEGF in Cancer 27
- Histone Deacetylase Inhibitors Research 17
-
- Prostate Cancer Treatment and Research 79
- Prostate Cancer Diagnosis and Treatment 21
- Co-authors
- Douglas K. Price (45 shared papers)William L. Dahut (38 shared papers)Alex Sparreboom (19 shared papers)Shannon C. Dixon (7 shared papers)Tristan M. Sissung (24 shared papers)Philip W. Kantoff (6 shared papers)Jürgen Venitz (12 shared papers)Seth M. Steinberg (17 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Cancer Biology & Therapy (24 papers)Journal of Chromatography B (9 papers)Clinical Cancer Research (8 papers)Neuro-Oncology (6 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
William D. Figg
229 papers receiving 10.0k citations
William D. Figg's Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 2.4k
- Pulmonary and Respiratory Medicine 3.8k
- Oncology 3.1k
- Hematology 950
- Molecular Biology 4.6k
Countries citing papers authored by William D. Figg
This map shows the geographic impact of William D. Figg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William D. Figg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William D. Figg more than expected).
Fields of papers citing papers by William D. Figg
This network shows the impact of papers produced by William D. Figg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William D. Figg. The network helps show where William D. Figg may publish in the future.
Co-authors
The 25 scholars most cited alongside William D. Figg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group Hit paper breakdown → | 2008 | 1696 |
| 2 | Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. | 2002 | 435 |
| 3 | 2000 | 342 | |
| 4 | 2007 | 264 | |
| 5 | 2004 | 257 | |
| 6 | 1998 | 246 | |
| 7 | 2005 | 195 | |
| 8 | 2001 | 172 | |
| 9 | 2008 | 172 | |
| 10 | 2002 | 168 | |
| 11 | 2013 | 159 | |
| 12 | A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer. | 1994 | 141 |
| 13 | 2011 | 139 | |
| 14 | 2005 | 137 | |
| 15 | 2009 | 137 | |
| 16 | 2009 | 133 | |
| 17 | 2006 | 129 | |
| 18 | 2001 | 128 | |
| 19 | 2008 | 124 | |
| 20 | Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. | 2001 | 117 |
About William D. Figg
William D. Figg is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Genetics, having authored 234 papers that have together received 10.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (79 papers), Cancer, Hypoxia, and Metabolism (31 papers), Cancer, Lipids, and Metabolism (27 papers), Angiogenesis and VEGF in Cancer (27 papers), Prostate Cancer Diagnosis and Treatment (21 papers), Cancer Treatment and Pharmacology (19 papers), Hormonal and reproductive studies (18 papers) and Histone Deacetylase Inhibitors Research (17 papers). The work is most often cited by research in Cancer Research (2.4k citations), Pulmonary and Respiratory Medicine (3.8k citations), Oncology (3.1k citations), Hematology (950 citations) and Molecular Biology (4.6k citations). William D. Figg has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Douglas K. Price, William L. Dahut, Alex Sparreboom, Shannon C. Dixon, Tristan M. Sissung, Philip W. Kantoff, Jürgen Venitz, Seth M. Steinberg, Ian F. Tannock and Tomasz M. Beer. Their work appears in journals such as Journal of Clinical Oncology, Cancer Biology & Therapy, Journal of Chromatography B, Clinical Cancer Research and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.